SENSITIVITY AND SPECIFICITY OF MODERN SCREENING FOR EVALUATION IN MODERN GYNECOLOGIC PATHOLOGY
DOI:
https://doi.org/10.37547/Keywords:
Artificial Intelligence, Doppler, obstetrics, training, ultrasoundAbstract
Diagnostic ultrasound (DUSI) is probably the most common modality used in obstetric practice. From A mode first described by Ian Donald for gynecology in the late 1950s, B mode in the 1970s, real-time and gray scale imaging in the early 1980s, Doppler a little later, sophisticated color Doppler in the 1990s, and 3D/quadruple ultrasound in the 2000s, DUS has not ceased to be closely associated with obstetric practice. The latest innovation is the use of artificial intelligence, which will undoubtedly play an increasing role in all aspects of our lives, including medicine and, in particular, obstetric ultrasound. In addition, new imaging techniques, enhanced training methods, improved workflow and ergonomics may also be developed in the future.
Downloads
References
Salomon, L.J.; Alfirevic, Z.; Berghella, V.; Bilardo, C.; Hernandez-Andrade, E.; Johnsen, S.L.; Kalache, K.; Leung, K.Y.; Malinger, G.; Munoz, H.; et al. ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet. Gynecol. 2011, 37, 116–126.
Anonymous. AIUM Practice Parameter for the Performance of Detailed Second- and Third-Trimester Diagnostic Obstetric Ultrasound Examinations. J. Ultrasound Med. 2019, 38, 3093–3100.
Anonymous. AIUM Practice Parameter for the Performance of Fetal Echocardiography. J. Ultrasound Med. 2020, 39, E5–E16.
Malinger, G.; Paladini, D.; Haratz, K.K.; Monteagudo, A.; Pilu, G.L.; Timor-Tritsch, I.E. ISUOG Practice Guidelines (updated): Sonographic examination of the fetal central nervous system. Part 1: Performance of screening examination and indications for targeted neurosonography. Ultrasound Obstet. Gynecol. 2020, 56, 476–484.
Paladini, D.; Malinger, G.; Birnbaum, R.; Monteagudo, A.; Pilu, G.; Salomon, L.J.; Timor-Tritsch, I.E. ISUOG Practice Guidelines (updated): Sonographic examination of the fetal central nervous system. Part 2: Performance of targeted neurosonography. Ultrasound Obstet. Gynecol. 2021, 57, 661–671.
Salomon, L.J.; Alfirevic, Z.; Audibert, F.; Kagan, K.O.; Paladini, D.; Yeo, G.; Raine-Fenning, N.; ISUOG Clinical Standards Committee. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet. Gynecol. 2014, 44, 122–123.
Kenkhuis, M.J.A.; Bakker, M.; Bardi, F.; Fontanella, F.; Bakker, M.K.; Fleurke-Rozema, J.H.; Bilardo, C.M. Effectiveness of a 12-13-week scan for the early diagnosis of fetal congenital anomalies in the cell-free DNA era. Ultrasound Obstet. Gynecol. 2018, 51, 463–469.
Ficara, A.; Syngelaki, A.; Hammami, A.; Akolekar, R.; Nicolaides, K.H. Value of routine ultrasound examination at 35–37 weeks’ gestation in diagnosis of fetal abnormalities. Ultrasound Obstet. Gynecol. 2020, 55, 75–80.
Edwards, L.; Hui, L. First and second trimester screening for fetal structural anomalies. Semin. Fetal. Neonatal. Med. 2018, 23, 102–111.
International Society of Ultrasound in Obstetrics and Gynecology; Carvalho, J.S.; Allan, L.D.; Chaoui, R.; Copel, J.A.; DeVore, G.R.; Hecher, K.; Lee, W.; Munoz, H.; Paladini, D.; et al. ISUOG Practice Guidelines (updated): Sonographic screening examination of the fetal heart. Ultrasound Obstet. Gynecol. 2013, 41, 348–359.
Platt, L.D. Should the first trimester ultrasound include anatomy survey? Semin. Perinatol. 2013, 37, 310–322. [Google Scholar] [CrossRef] [PubMed]
Pooh, R.K.; Kurjak, A. 3D/4D sonography moved prenatal diagnosis of fetal anomalies from the second to the first trimester of pregnancy. J. Matern. Fetal. Neonatal. Med. 2012, 25, 433–455.
Paladini, D.; Vassallo, M.; Tartaglione, A.; Lapadula, C.; Martinelli, P. The role of tissue harmonic imaging in fetal echocardiography. Ultrasound Obstet. Gynecol. 2004, 23, 159–164.
Biard, J.-M.; Steenhaut, P.; Bernard, P.; Race, V.; Sznajer, Y. Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019, 240, 232–241.
Mak, A.S.L.; Ma, T.W.L.; Chan, K.Y.K.; Kan, A.S.Y.; Tang, M.H.Y.; Leung, K.Y. Prenatal diagnosis of 5p deletion syndrome: Report of five cases. J. Obstet. Gynaecol. Res. 2019, 45, 923–926.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
